Breast Cancer Combination Therapy for Operable Breast Cancer: Paclitaxel, Carboplatin, Bevacizumab, Doxorubicin, and Cyclophosphamide Apr 26, 2023
Breast Cancer Promising Results of Talazoparib in BRCA-Mutated Metastatic Breast Cancer from the EMBRACA Trial Apr 26, 2023
Breast Cancer Sacituzumab Govitecan in Primary HER2-Negative Breast Cancer: A Promising Targeted Therapy Apr 26, 2023
Breast Cancer T-DM1 and Tucatinib Combination Therapy in Preventing Relapses of HER2+ Breast Cancer Apr 26, 2023
Breast Cancer Phase 2 FAKTION Study: Treatment for Advanced Aromatase Inhibitor Resistant Breast Cancer Apr 21, 2023
Breast Cancer Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Metastatic TNBC Apr 21, 2023
